In this video interview, Michel van Harten, MD, CEO, myTomorrows, discusses how patient education and remote monitoring can help with reducing the burden of trial participation.

Clinical trials are essential for advancing medical treatments, yet participation from Black communities remains low due to misinformation.

Clinical trials are a crucial step in medical research, and without adequate numbers of participants, treatments can be ...

Since joining the Lupus Research Alliance (LRA) in 2015, Albert T. Roy has risen to the role of president and CEO. During ...

Health professionals and advocates shared experiences and insights on the critical importance of Black participation in medical research.

Discover what really happens in clinical trials. From potential benefits to hidden risks, learn what participants experience ...

Looking at those barriers, it is estimated ... approximately 20% of cancer clinical trials fail due to insufficient patient participation," Shackleford said. The measure was approved 95-0 by ...

Removing barriers to clinical trial participation for underserved groups is an essential part of addressing health inequalities. Getting there, however, is easier said than done. The Food and Drug ...

We need to make clinical trial participation a seamless experience for patients, build relationships between patients and site staff, and remove logistical barriers to participation for the good ...

Clinicians and scientists from RWJBarnabas Health and Rutgers Cancer Institute will share new findings and lead discussions ...

Calif., who represents Imperial County, and Rep. August Pfluger, R-Texas, introduced bipartisan legislation aimed at removing ...